Aprogen pharmaceuticals,Inc.

KRX:003060.KS

805 (KRW) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Assets:
Current Assets:
Cash & Cash Equivalents 10,053.3623,608.84335,074.0964,795.65530,296.95521,630.49523,784.45726,216.12417,928.0629,332.0417,973.14114,204.05212,772.5392,253.1052,966.2832,281.2912,934.54
Short Term Investments 075,464.77489,861.208140,279.11962,212.84640,832.0669,612.98532,110.3579,250.74817,712.7054,057.9632,242.145,133.8952,399.895402.205786.67870
Cash and Short Term Investments 10,053.3699,073.617124,935.298205,074.77492,509.80162,462.56133,397.44258,326.48127,178.8127,044.74522,031.10416,446.19217,906.4344,6533,368.4883,067.9613,804.54
Net Receivables 26,198.86289,459.344222,300.233125,447.437118,021.816,402.75223,774.11616,628.13315,468.37714,867.06215,662.44640,742.79441,461.11933,668.398008,276.237
Inventory 48,128.19552,312.92110,419.59910,039.6528,758.1268,398.5428,836.1598,114.0666,490.1946,670.5885,710.7367,645.7735,605.4727,274.9527,524.5317,637.3334,707.491
Other Current Assets 476.868-237.753-4,180.851-4,039.08-5,743.62623.090000.001-0.001-0.001-0.001-0.00222,657.3277,783.924-0.001
Total Current Assets 84,857.286240,608.129353,474.278336,522.784213,546.10187,286.94466,007.71783,068.6849,137.38248,582.39643,404.28664,834.75864,973.02445,596.34833,550.34618,489.21816,788.267
Non-Current Assets:
Property, Plant & Equipment, Net 318,211.931323,773.10718,856.6219,800.74945,907.24517,327.2518,164.02125,947.98425,110.76922,586.64621,199.54712,537.82219,903.43823,016.1286,468.3422,125.393,950.246
Goodwill 000000000172.811172.8113,077.2743,077.5742,934.0743,468.472426.37738
Intangible Assets 6,240.8536,458.1052,796.4063,635.2273,508.883,290.4934,517.7734,893.4994,126.3871,990.5311,800.3911,632.5291,637.398767.988276.739766.48587.197
Goodwill and Intangible Assets 6,240.8536,458.1052,796.4063,635.2273,508.883,290.4934,517.7734,893.4994,126.3872,163.3421,973.2024,709.8034,714.9723,702.0623,745.2111,192.862125.197
Long Term Investments 180,058.612-17,671.765-5,628.993-36,179.76229,753.90166,688.67864,377.87-22,783.013-8,114.474-11,385.2771,627.114,682.59417,469.9982,931.12214,404.9936,236.5697,909.721
Tax Assets 0662.841755.702658.885793.39749.414696.807669.036863.47522,880.9119,854.5276,117.3849,071.6870897.8152,510.021,211.962
Other Non-Current Assets 27.982122,272.934244,367.09290,871.2571,773.46141,719.2674,507.89936,894.41214,097.755-0200.548200.549200.5493,453.882-0.0011,054.1821,048.182
Total Non-Current Assets 504,539.379435,495.222261,146.825278,786.35151,736.877129,775.10392,264.3745,621.91936,083.91336,245.62234,854.93428,248.15351,360.64333,103.19425,516.3613,119.02314,245.308
Total Assets 589,396.665676,103.351614,621.103615,309.134365,282.978217,062.048158,272.087128,690.59985,221.29584,828.01878,259.2293,082.911116,333.66778,699.54259,066.70731,608.2431,033.575
Liabilities & Equity:
Current Liabilities:
Account Payables 1,333.0663,808.672652.594808.222535.877707.679489.296520.463653.572341.733601.0081,446.6611,150.2282,039.4121,070.8192,962.457668.757
Short Term Debt 130,720.461134,608.9012,361.132,806.8733,635.0538,009.95226,756.84635,960.8664,523.4215,661.2522,372.44911,471.4827,509.71416,653.12324,490.6535,333.72717,535.369
Tax Payables 409.7834.176273.932461.172079.158191.987358.309199.55417.714000798.929101.407124.581129.51
Deferred Revenue 194.339543.1656,435.0755,059.8586,643.86323,325.15708,668.7324,708.0444,396.4036,556.1775,644.6265,332.3659,555.23602,043.9892,082.46
Other Current Liabilities 25,690.50322,145.32000.00106,723.4190.0010.001-015263.46375.1680.0016,178.0290.0010.001
Total Current Liabilities 157,938.368161,106.0589,448.7998,674.95310,814.7962,042.78833,969.56245,150.0629,885.03810,399.3889,544.63418,826.2334,067.47528,247.77231,739.50110,340.17420,286.587
Non-Current Liabilities:
Long Term Debt 32,000129.058120163.917228.019024,893.8231,0804,139.168,395.328,332.1122,294.0714,0335,3700778.0380
Deferred Revenue Non-Current 18,276.833007,186.4830000000000000
Deferred Tax Liabilities Non-Current 2,931.5183,108.1061,093.389927.5770000000000000
Other Non-Current Liabilities 9,558.4679,386.476,778.036-06,603.1984,508.37421,548.0544,340.0573,451.813,920.0813,835.7463,454.844,744.7512,275.0842,150.8962.548627.832
Total Non-Current Liabilities 62,766.81912,623.6347,991.4258,277.9776,831.2174,508.37446,441.8775,420.0577,590.9712,315.40112,167.8585,748.9118,777.7517,645.0842,150.81,740.586627.832
Total Liabilities 220,705.187173,729.69217,440.22416,952.9317,646.00766,551.16280,411.43950,570.11817,476.00822,714.78821,712.49224,575.14142,845.22535,892.85733,890.30112,080.7620,914.418
Equity:
Preferred Stock 00000000000000000
Common Stock 332,877.345292,877.344199,287.884199,287.884120,829.16453,941.09742,314.46440,437.47440,286.57477,389.94767,436.31559,361.21824,557.52913,200.613,689.62828,721.80418,691.531
Retained Earnings -328,848.013-12,887.68-21,114.746-30,114.077-41,771.364-33,283.698-27,440.826-10,858.64-6,352.406-49,836.279-45,066.692-29,029.305-4,182.322-704.422-23,651.683-15,554.182-16,054.183
Accumulated Other Comprehensive Income/Loss 11,094.8845,859.8112,503.6278,964.0242,081.42210,151.10614,195.4871,280.5481,548.6900000000
Other Total Stockholders Equity 353,567.262135,869.436327,261.841327,257.068165,203.519119,702.38148,791.52349,545.59633,742.30634,775.95333,884.97138,175.85653,113.23530,310.49744,975.0755,182.8847,481.809
Total Shareholders Equity 368,691.478421,718.911507,938.605505,394.898246,342.741150,510.88677,860.64880,404.97769,225.16362,329.62156,254.59468,507.76973,488.44242,806.68525,013.0218,350.50610,119.157
Total Equity 368,691.478502,373.659597,180.878598,356.204347,636.971150,510.88677,860.64878,120.48167,745.28762,113.22856,546.72868,507.76973,488.44242,806.68525,176.40619,527.4810,119.157
Total Liabilities & Shareholders Equity 589,396.665676,103.351614,621.103615,309.134365,282.978217,062.048158,272.087128,690.59985,221.29584,828.01778,259.2293,082.91116,333.66778,699.54259,066.70731,608.2431,033.575